Back to results
US 2025/0019383 A1Published application
Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
AssigneeViiV HEALTHCARE UK (NO. 5) LIMITED
InventorsEric P. GILLIS, Christiana IWUAGWU
Life of this patent
Estimating the term…
Abstract
The compound and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
Claims2
1-15. (canceled)
A method of treating HIV infection in a human comprising administration of an effective amount of compound or pharmaceutically acceptable salt thereof, which is:
- in combination with a compound selected from a nucleotide reverse transcriptase inhibitor, a non-nucleotide reverse transcriptase inhibitor, a protease inhibitor, an integrase strand transfer inhibitor, and an entry inhibitor, to said human.
Dependencies are inferred from the claim text.